The Medtronic Amplia MRI™ Quad CRT-D SureScan™ (Model DTMB2QQ) is an implantable cardiac resynchronization therapy defibrillator designed for patients with heart failure who are also at risk of sudden cardiac death. It is a "biventricular" device, meaning it uses three leads to pace both sides of the heart to improve pumping efficiency.
Key Features of the DTMB2QQ Model:
- MRI Compatibility: Features SureScan™ technology, allowing for full-body 1.5T and 3T MRI scans under specific conditions.
- Quadripolar Technology: Provides "Quad" capabilities, allowing for more options in left ventricular lead placement to optimize therapy.
- Advanced Algorithms: Uses AdaptivCRT™ to automatically adjust therapy based on patient needs, and CardioSync™ for optimization.
- Design: Features a PhysioCurve™ design to enhance patient comfort.
- Battery: Uses a hybrid CFx lithium/silver vanadium oxide battery.
